Home
Scholarly Works
Reply to: Rong Dai and Changkai Deng’s Letter to...
Journal article

Reply to: Rong Dai and Changkai Deng’s Letter to the Editor re: Anirban Dey, Georgios Georgiadis, Justin Umezurike, et al. Mirabegron Versus Placebo and Other Therapeutic Modalities in the Treatment of Patients with Overactive Bladder Syndrome—A Systematic Review. Eur Urol Focus. 2025;11:237–250. https://doi.org/10.1016/j.euf.2024.09.012

Authors

Dey A; Georgiadis G; Umezurike J; Yuan Y; Farag F; N'Dow J; Omar MI; Mamoulakis C

Journal

European Urology Focus, Vol. 11, No. 3, pp. 531–532

Publisher

Elsevier

Publication Date

May 1, 2025

DOI

10.1016/j.euf.2024.12.004

ISSN

2405-4569

Contact the Experts team